Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara B Bendlin

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
JAMA Neurology|May 2, 2017
Incorrect Scaling Factor and Errors in Figures and P Value ThresholdsBarbara B Bendlin
Dialogues in Clinical Neuroscience|October 15, 2019
Antidiabetic therapies and Alzheimer diseaseBarbara B Bendlin
Neurology|January 8, 2017
Blood-based biomarkers for evaluating sport-related concussion: Back in the gameBarbara B Bendlin, Michael Makdissi
Neurology|August 3, 2019
Screening with a high-precision blood-based assay for Alzheimer diseaseBarbara B Bendlin, Henrik Zetterberg
Nature|February 4, 2026
Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementiasHenrik Zetterberg, Barbara B Bendlin
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 18, 2022
The iterative process of fluid biomarker development and validation in Alzheimer's diseaseBarbara B Bendlin, Henrik Zetterberg
The Lancet. Healthy Longevity|September 13, 2022
Neurodegenerative dementias: screening for major threats to healthy longevity with blood biomarkersHenrik Zetterberg, Barbara B Bendlin
Molecular Psychiatry|April 7, 2020
Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapiesHenrik Zetterberg, Barbara B Bendlin
The Lancet. Diabetes & Endocrinology|August 3, 2020
The link between type 2 diabetes and dementia: from biomarkers to treatmentMichal Schnaider Beeri, Barbara B Bendlin
JAMA Neurology|January 1, 2016
Confounders Regarding the Association of Insulin Resistance and Alzheimer Disease--ReplyAuriel A Willette, Barbara B Bendlin
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
JAMA Neurology|May 2, 2017
Incorrect Scaling Factor and Errors in Figures and P Value ThresholdsBarbara B Bendlin
Dialogues in Clinical Neuroscience|October 15, 2019
Antidiabetic therapies and Alzheimer diseaseBarbara B Bendlin
Neurology|January 8, 2017
Blood-based biomarkers for evaluating sport-related concussion: Back in the gameBarbara B Bendlin, Michael Makdissi
Neurology|August 3, 2019
Screening with a high-precision blood-based assay for Alzheimer diseaseBarbara B Bendlin, Henrik Zetterberg
Nature|February 4, 2026
Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementiasHenrik Zetterberg, Barbara B Bendlin
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 18, 2022
The iterative process of fluid biomarker development and validation in Alzheimer's diseaseBarbara B Bendlin, Henrik Zetterberg
The Lancet. Healthy Longevity|September 13, 2022
Neurodegenerative dementias: screening for major threats to healthy longevity with blood biomarkersHenrik Zetterberg, Barbara B Bendlin
Molecular Psychiatry|April 7, 2020
Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapiesHenrik Zetterberg, Barbara B Bendlin
The Lancet. Diabetes & Endocrinology|August 3, 2020
The link between type 2 diabetes and dementia: from biomarkers to treatmentMichal Schnaider Beeri, Barbara B Bendlin
JAMA Neurology|January 1, 2016
Confounders Regarding the Association of Insulin Resistance and Alzheimer Disease--ReplyAuriel A Willette, Barbara B Bendlin
Pageof 26